137 | IBRUTINIB ADDED TO MCL TREATMENT HAS STRONG IMPACT ON MRD RESPONSE AND DISEASE KINETICS: RESULTS FROM THE TRIANGLE TRIAL
Mouhamad Khouja(University Hospital Schleswig-Holstein), Christiane Pott(University Hospital Schleswig-Holstein), Simone Ferrero(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), M. Gomes da Silva, Ana Milena Herrera(Instituto de Investigación Biomédica de Salamanca), Susanne Kubetzko(University Children's Hospital Zurich), Eva Hoster(Zimmer Biomet (Germany)), Paula Gameiro(IPO Porto), Jon Riise(Oslo University Hospital), Britta Kehden(University Hospital Schleswig-Holstein), Ulrich Mey(Kantonsspital Graubünden), Sirpa Leppä(University of Helsinki), Eva Giné(Aristotle University of Thessaloniki), Elisa Genuardi(University of Turin), Jan Walewski(The Maria Sklodowska-Curie National Research Institute of Oncology), Christian Schmidt, Carsten Utoft Niemann(Copenhagen University Hospital), Ofer Shpilberg(Texas Oncology), Vindi Jurinović(Ludwig-Maximilians-Universität München), O. J. H. M. Verhagen(Sanquin), Eva Froňková(Charles University), Martin Hutchings(University of Copenhagen), V. K. Vergote, Marco Ladetto(Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo), Aurora Maria Civita(University of Turin), Marek Trněný(The University of Texas System), M. Dreyling(Ludwig-Maximilians-Universität München), Wolfgang Hiddemann(Christian-Albrechts-Universität zu Kiel), Michael Unterhalt, V.H. van der Velden(Erasmus MC), Christa Homburg(Sanquin), M. Jerkemann(Lund University), Jeanette K. Doorduijn(Université Paris Cité)
Cited by 1
Related Papers
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling
|New England Journal of Medicine|2006|1k
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|920